• Issue

    Catheterization and Cardiovascular Interventions: Volume 97, Issue 6

    i-viii, 1109-1308, E748-E899
    May 1, 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION - COPYRIGHT

Free Access

Issue Information - Copyright

  • Page: i
  • First Published: 11 May 2021

ISSUE INFORMATION - EDITORIAL BOARD

Free Access

Issue Information - Editorial Board

  • Page: ii
  • First Published: 11 May 2021

ISSUE INFORMATION - TOC

Free Access

Issue Information - TOC

  • Pages: iv-viii
  • First Published: 11 May 2021

CORONARY ARTERY DISEASE

ORIGINAL STUDIES

Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003–2018

Santiago Garcia MD,  Christian W. Schmidt MPH,  Ross Garberich MS, MBA,  Timothy D. Henry MD,  Steven M. Bradley MD, MPH,  Emmanouil S. Brilakis MD, PhD,  Nickolas Burke MD,  Ivan J. Chavez MD,  Peter Eckman MD,  Mario Gössl MD, PhD,  Michael R. Mooney MD,  Marc C. Newell MD,  Anil K. Poulose MD,  Paul Sorajja MD,  Jay H. Traverse MD,  Yale L. Wang MD,  Scott W. Sharkey MD, 
  • Pages: 1109-1117
  • First Published: 15 April 2020

EDITORIAL COMMENT

The remnant of our success

Patrick Prior MD,  William A. Gray MD, 
  • Pages: 1118-1119
  • First Published: 11 May 2021
Key Points

  • Mortality associated with ST-elevation myocardial infarction (STEMI) has increased despite improved door to balloon times due to increased patient complexity with more patients presenting to the catheterization lab with cardiac arrest and cardiogenic shock.
  • Emphasis on multimodal treatments of STEMI patients presenting with cardiogenic shock including early percutaneous coronary intervention with circulatory support when appropriate will likely provide the best clinical outcomes.
  • Future research should involve continued study of clinical outcomes in STEMI patients as use of various mechanical support increases.

ORIGINAL STUDIES

Open Access

One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study

Shmuel Chen MD, PhD,  Shukri W. David MD,  Zubair A. Khan MD,  D. Christopher Metzger MD,  Hal S. Wasserman MD,  Amir S. Lotfi MD,  Ivan D. Hanson MD,  Simon R. Dixon MBChB,  Thomas A. LaLonde MD,  Philippe Généreux MD,  M. Ozgu Ozan MS,  Akiko Maehara MD,  Gregg W. Stone MD, 
  • Pages: 1120-1126
  • First Published: 10 July 2020

EDITORIAL COMMENT

Supersaturated oxygen therapy in acute anterior myocardial infarction: Going small is the next big thing

Khansa Ahmad MD,  J. Dawn Abbott MD, 
  • Pages: 1127-1128
  • First Published: 11 May 2021
Key Points

  • Improving myocardial salvage and reducing infarct size to optimize post-myocardial infarction sequelae of heart failure and mortality remain an important goal in the primary PCI era.
  • Intra-coronary supersaturated oxygen therapy is relatively new with unknown long-term outcomes.
  • The current study presents evidence of improved clinical outcomes after supersaturated oxygen therapy but is limited in size and study design necessitating further investigation before widespread adoption.

ORIGINAL STUDIES

Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock

Mohit Pahuja MD,  Sagar Ranka MD,  Omar Chehab MD, MSc,  Tushar Mishra MD,  Emmanuel Akintoye MD, MPH,  Oluwole Adegbala MD, MPH,  Ahmed S. Yassin MD,  Tomo Ando MD,  Katherine L. Thayer MPH,  Palak Shah MD,  Carey D. Kimmelstiel MD,  Payam Salehi MD,  Navin K. Kapur MD, 
  • Pages: 1129-1138
  • First Published: 30 May 2020

EDITORIAL COMMENT

Lies, damned lies, and statistics, but bleeding and acute limb ischemia are facts!

Abdulla A. Damluji MD, PhD,  Ian C. Gilchrist MD, MSCAI, 
  • Pages: 1139-1140
  • First Published: 11 May 2021
Key Points

  • Bleeding and ischemic limb complications continue to plague patients with cardiogenic shock.
  • These complications are iatrogenic as they are not part of the pathophysiology of cardiogenic shock syndrome and are an attractive target for quality improvement.
  • Standardized care with vascular bundles may represent an important concept to reduce complications in this high-risk patient group.

ORIGINAL STUDIES

Impact of manual thrombectomy on microvascular obstruction in STEMI patients

David Meier MD,  Stephane Fournier MD,  Pier G. Masci MD,  Eric Eeckhout MD,  Panagiotis Antiochos MD,  Georgios Tzimas MD,  Nikolay Stoyanov MD,  Muenpetch Muenkaew MD,  Pierre Monney MD,  Juerg Schwitter MD,  Olivier Muller MD, PhD,  Brahim Harbaoui MD, PhD, 
  • Pages: 1141-1148
  • First Published: 11 April 2020

EDITORIAL COMMENT

The inconsistency of manual thrombectomy and the role of contemporary thrombus grading in PCI for STEMI

On Topaz MD, FACC, FACP, FSCAI, 
  • Pages: 1149-1150
  • First Published: 11 May 2021
Key Points

  • Manual thrombectomy (MT) is a negative determinant for MVO occurrence and extent in STEMI patients with a high thrombus grade.
  • Integration of contemporary thrombus grading classification is essential to ensure efficacious and safe PCI.
  • Aiming to reduce MVO occurrence and extent in STEMI patients indicates a role for power sourced, real mechanical thrombectomy devices as the preferred revascularization tools in heavy thrombus burden.

ORIGINAL STUDIES

Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification

Min Chul Kim MD, PhD,  SungA Bae MD,  Youngkeun Ahn MD, PhD,  Doo Sun Sim MD, PhD,  Young Joon Hong MD, PhD,  Ju Han Kim MD, PhD,  Myung Ho Jeong MD, PhD,  Hyo-Soo Kim MD, PhD,  Shung Chull Chae MD, PhD,  Kwang Soo Cha MD, PhD,  Other Korea Acute Myocardial Infarction Registry Investigators , 
  • Pages: 1151-1159
  • First Published: 22 June 2020

EDITORIAL COMMENT

GRACEfully assessing the timeline for noninfarct-related artery intervention in ST-elevation myocardial infarction patients

Jay Shah MD,  Michael S. Levy MD, MPH, 
  • Pages: 1160-1161
  • First Published: 11 May 2021
Key Points

  • A large registry study of ST-elevation myocardial infarction (STEMI) patients with multivessel disease and without cardiogenic shock demonstrated that staged in-hospital intervention of the noninfarct-related artery was associated with a reduced risk of all-cause mortality when compared to culprit-only PCI or immediate multivessel intervention.
  • A subgroup analysis stratified by the Global Registry of Acute Coronary Events (GRACE) score, showed a mortality benefit in high-risk patients (GRACE score > 140) undergoing staged in-hospital intervention of the noninfarct-related artery with a median interval between the two procedures of 5 days.
  • Further large, randomized trials are needed to help clarify appropriate timing for nonculprit staged intervention in STEMI patients.

ORIGINAL STUDIES

Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry

Sanjog Kalra MD, MSc,  Darshan Doshi MD, MS,  James Sapontis MBBCh,  Ioanna Kosmidou MD, PhD,  Ajay J. Kirtane MD, SM,  Jeffrey W. Moses MD,  Robert F. Riley MD, MS,  Philip Jones MS,  William J. Nicholson MD,  Adam C. Salisbury MD, MSc,  William L. Lombardi MD,  James M. McCabe MD,  Ashish Pershad MD,  Taishi Hirai MD,  Emad Hakemi MD,  Juan J. Russo MD,  Megha Prasad MD,  Yousif Ahmad MD,  Raja Hatem MD,  Fotis Gkargkoulas MD,  John A. Spertus MD, MPH,  R. Michael Wyman MD,  Farouc Jaffer MD, PhD,  Anthony Spaedy MD,  Stephen Cook MD,  Steven P. Marso MD,  Karen Nugent RRT,  Robert Federici MD,  Robert W. Yeh MD, MBA,  Martin B. Leon MD,  Gregg W. Stone MD,  Ziad A. Ali MD, DPhil,  Manish A. Parikh MD,  Akiko Maehara MD,  David J. Cohen MD, MSc,  Candido Batres MD,  J. Aaron Grantham MD,  Dimitri Karmpaliotis MD, PhD, 
  • Pages: 1162-1173
  • First Published: 02 September 2020

EDITORIAL COMMENT

With great power comes great responsibility: When and how to use the retrograde approach to chronic total occlusion interventions

Raviteja R. Guddeti MD,  Emmanouil S. Brilakis MD, PhD, 
  • Pages: 1174-1175
  • First Published: 11 May 2021
Key Points

  • The retrograde approach to chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is a powerful tool for successful CTO crossing, especially in complex occlusions.
  • Compared with antegrade-only CTO PCI, the retrograde approach is associated with increased risk of periprocedural complications.
  • The retrograde approach should be used when the anticipated benefits outweigh the potential risks and should be performed in a meticulous, systematic, and stepwise fashion to maximize the likelihood of success and minimize the risk of complications.

ORIGINAL STUDIES

Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion—A subanalysis of the EXPLORE trial

Maarten Z. H. Kolk,  Anna van Veelen MD,  Pierfrancesco Agostoni MD, PhD,  Gert K. van Houwelingen MD,  Dagmar M. Ouweneel MSc, PhD,  Loes P. Hoebers MD, PhD,  Truls Råmunddal MD, PhD,  Peep Laanmets MD,  Erlend Eriksen MD,  Matthijs Bax MD,  Maarten J. Suttorp MD, PhD,  Bimmer E. P. M. Claessen MD, PhD,  René J. van der Schaaf MD, PhD,  Joëlle Elias MD, PhD,  Ivo M. van Dongen MD, PhD,  José P. S. Henriques MD, PhD, 
  • Pages: 1176-1183
  • First Published: 15 April 2020

EDITORIAL COMMENT

Chronic coronary total occlusions: Let's make the long story short

Sahil Khera MD, MPH, FSCAI,  George D. Dangas MD, PhD, MSCAI, 
  • Pages: 1184-1185
  • First Published: 11 May 2021
Key Points

  • Noninfarct-related chronic total occlusions are encountered approximately in 15% of patients presenting with acute ST-elevation myocardial infarction.
  • The presence of noninfarct-related chronic total occlusion portends worse mid- and long-term clinical outcomes in accordance with the “spare tire” hypothesis.
  • Numerous risk scores have been developed for ascertaining procedural success for chronic total occlusion percutaneous coronary interventions.
  • Complete occlusion length over 20 mm is a readily available, important factor for unsuccessful chronic total occlusion recanalization, both in stable coronary artery disease and in patients with noninfarct-related chronic total occlusion.

ORIGINAL STUDIES

Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study

Christian Patterson BA,  James Sapontis MBBCh,  William J. Nicholson MD,  William Lombardi MD,  Dimitri Karmpaliotis MD,  Jeffrey Moses MD,  Kensey L. Gosch MS,  J. Aaron Grantham MD,  Taishi Hirai MD,  OPEN CTO Study Group , 
  • Pages: 1186-1193
  • First Published: 22 April 2020

EDITORIAL COMMENT

The enigma continues: Obesity in chronic total occlusion patients does not affect success or complications…but Americans are still too fat!

Nachiket J. Patel MD, FACC, FACP, FSCAI,  Richard R. Heuser MD, FACC, FACP, FESC, MSCAI, 
  • Pages: 1194-1195
  • First Published: 11 May 2021
Key Points

  • Eighty-five percent of patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in the OPEN-CTO registry were either overweight or obese.
  • There is no difference in procedure success and outcomes between overweight and obese patients undergoing CTO PCI compared to normal weight.
  • Overweight and obese patients derive similar health status benefits after CTO PCI.

ORIGINAL STUDIES

Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention

Gerald S. Werner MD PhD,  Kenji Yaginuma MD,  Matthias Koch MD,  Karlheinz Tischer MD,  Martin Silber PhD,  Juliane Werner MD,  Thomas Keuser MD,  Hiller Moehlis MD, 
  • Pages: 1196-1206
  • First Published: 15 July 2020

EDITORIAL COMMENT

Achieving radiation reduction by adapting to technology advances

Stephen Balter PhD,  Jeffrey W. Moses MD, 
  • Pages: 1207-1208
  • First Published: 11 May 2021
Key Points

  • This study demonstrates that the combination of image processing enhancements along with meticulous attention by operators to radiation hygiene can lead to significant and clinically meaningful reductions in radiation exposure.
  • The results obtained from a single experienced chronic total occlusion (CTO) operator in two sequential time periods are a reasonable substitute for a randomized trial.
  • Radiation exposure to patients and operators remains a significant hazard of CTO procedures.
  • Avoiding excessive dosage removes a barrier to successful procedural completion.

CASE REPORTS

Unmasking right ventricular failure in cardiogenic shock: The importance of serial hemodynamics

Alejandro Lemor MD,  Waleed Al-Darzi MBBCh,  William O'Neill MD,  Mir Babar Basir DO, 
  • Pages: 1209-1212
  • First Published: 23 January 2021

An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium

Srikanth Adusumalli MD,  Rustem Dautov MD, PhD, 
  • Pages: 1213-1217
  • First Published: 07 February 2021

Colossal left main to right atrium fistula ligation complicated by left circumflex STEMI

Giorgio A. Medranda MD,  Shannon Lance DO,  Ron Waksman MD,  Nelson L. Bernardo MD, 
  • Pages: 1218-1220
  • First Published: 17 October 2020

CORE CURRICULUM

The role of rivaroxaban for patients with atherosclerotic vascular disease in the modern era

Joshua C. Vogt MD,  Patrick G. Manning MD,  Omar Sheikh MD,  Herbert D. Aronow MD, MPH,  Robert J. Chilton DO,  Joaquin E. Cigarroa MD, 
  • Pages: 1221-1229
  • First Published: 08 July 2020

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair

Neila Sayah MD,  Francois Simon MD,  Patrick Garceau MD,  Anique Ducharme MSc, MD,  Arsene Basmadjian MSc, MD,  Denis Bouchard MD, PhD,  Michel Pellerin MD,  Raoul Bonan MD,  Anita W. Asgar MD, MSc, 
  • Pages: 1230-1234
  • First Published: 11 November 2020

EDITORIAL COMMENT

More energy, more costs

Prakash Balan MD,  Marvin H. Eng MD, 
  • Page: 1235
  • First Published: 11 May 2021
Key Points

  • Transseptal access has been widely disseminated with a relatively low complication rate.
  • The VersaCross Transseptal system utilizes radiofrequency energy to facilitate transseptal access enhancing ease and efficiency of procedures.
  • Rising costs of structural heart interventions may impact resource allocation for medical devices.

ORIGINAL STUDIES

Open Access

Impact of cleft-like indentations on procedural outcome of percutaneous edge-to-edge mitral valve repair

Maria Isabel Körber MD,  Kai Peter Friedrichs MD,  Fatma Aydin,  Roman Pfister MD,  Victor Mauri MD,  Stephan Baldus MD,  Volker Rudolph MD,  Michael Huntgeburth MD, 
  • Pages: 1236-1243
  • First Published: 01 October 2020

30-day patient reported outcomes can be predicted by change in left atrial pressure and not change in transmitral gradient following MitraClip

Keniel Pierre MD,  Demilade A. Adedinsewo MD, MPH,  Mohammed Al-Hijji MD,  William R. Miranda MD,  Mohamad Alkhouli MD,  Mackram F. Eleid MD,  Mayra Guerrero MD,  Peter M. Pollak MD,  Charanjit S. Rihal MD,  Abdallah El Sabbagh MD, 
  • Pages: 1244-1249
  • First Published: 27 January 2021

EDITORIAL COMMENT

Should the mean left atrial pressure be the ultimate goal after TMVR?

Mehmet Cilingiroglu MD,  Konstantinos Marmagkiolis MD, 
  • Pages: 1250-1251
  • First Published: 11 May 2021
Key Points

  • Transcatheter mitral valve repair (TMVR) using Mitraclip is now the standard of care for treatment of severe symptomatic mitral regurgitation (MR) in patients who are at high-surgical risk.
  • Although acute reduction in regurgitant MR volume has been the main goal of successful treatment, many other hemodynamic parameters also important for accurate assessment and confirmation of the acute procedural outcome.
  • Acute reduction of the mean left atrial pressure (MLAP) following TMVR seems to be well correlated with successful clinical outcomes at 30 days.

ORIGINAL STUDIES

Impact of atrial fibrillation on outcomes following MitraClip: A contemporary population-based analysis

Anas M. Saad MD,  Nicholas Kassis MD,  Mohamed M. Gad MD,  Omar Abdelfattah MD,  Keerat R. Ahuja MD,  Medhat Farwati MD,  Toshiaki Isogai MD, MPH,  Najdat Bazarbashi MD,  Shashank Shekhar MD,  Samir R. Kapadia MD, 
  • Pages: 1252-1256
  • First Published: 05 October 2020

EDITORIAL COMMENT

Clipping mitral valve or atrial fibrillation? Two is better than one!

Tiziana Claudia Aranzulla MD, MSc,  Giuseppe Musumeci MD, 
  • Pages: 1257-1258
  • First Published: 11 May 2021
Key Points

  • Patients with atrial fibrillation (AF) undergoing MitraClip experience a doubled risk of in-hospital stroke and higher 30-day mortality.
  • Strategies to prevent in-hospital stroke in AF patients undergoing MitraClip may involve both pre- and intra-procedural management.
  • Specific trials are needed to assess the impact of uninterrupted anticoagulation, early heparinization, and previous AF ablation on outcome following MitraClip.

ORIGINAL STUDIES

Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry)

Rodrigo Estévez-Loureiro MD, PhD,  Mony Shuvy MD,  Maurizio Taramasso MD, PhD,  Tomas Benito-Gonzalez MD,  Paolo Denti MD, PhD,  Dabit Arzamendi MD, PhD,  Marianna Adamo MD,  Xavier Freixa MD, PhD,  Pedro Villablanca MD, MSc,  Lian Krivoshei MD,  Neil Fam MD, PhD,  Konstantinos Spargias MD,  Andrew Czarnecki MD,  Dan Haberman MD,  Yoram Agmon MD,  Doron Sudarsky MD,  Isaac Pascual MD, PhD,  Vlasis Ninios MD,  Salvatore Scianna MD,  Igal Moaraf MD,  Davide Schiavi MD,  Michael Chrissoheris MD,  Ronen Beeri MD,  Arthur Kerner MD,  Estefanía Fernández-Peregrina MD,  Mattia Di Pasquale MD,  Ander Regueiro MD, PhD,  Lion Poles MD,  Andres Iñiguez-Romo MD, PhD,  Felipe Fernández-Vázquez MD, PhD,  Francesco Maisano MD, 
  • Pages: 1259-1267
  • First Published: 18 February 2021

EDITORIAL COMMENT

Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction

Giuseppe Tarantini MD, PhD, FESC,  Chiara Fraccaro MD, PhD, 
  • Pages: 1268-1269
  • First Published: 11 May 2021
Key Points

  • Acute mitral regurgitation after myocardial infarction is associated with high mortality and morbidity.
  • Treatment with the MitraClip is associated with high procedural success and acceptable mortality whether they presented in or out of cardiogenic shock, provided initial hemodynamic stabilization was first achieved before PMVR.
  • This transcatheter technique represents a valid alternative for selected patients and prospective studies are warranted to inform patient selection and periprocedural management in this acute setting.

ORIGINAL STUDIES

Open Access

Dedicated plug based closure for large bore access –The MARVEL prospective registry

Herbert G. Kroon MD,  Pim A.L. Tonino MD PhD,  Mikko Savontaus MD PhD,  Giovanni Amoroso MD PhD,  Mika Laine MD PhD,  Evald H. Christiansen MD PhD,  Stefan Toggweiler MD PhD,  Jur ten Berg MD PhD,  Janarthanan Sathananthan MBChB MPH,  Joost Daemen MD, PhD,  Peter P. de Jaegere MD, PhD,  Guus B.R.G. Brueren MD PhD,  Markus Malmberg MD, PhD,  Ton Slagboom MD PhD,  Noriaki Moriyama MD,  Christian J. Terkelsen MD PhD,  Federico Moccetti MD,  Livia Gheorghe MD,  John Webb MD,  David Wood MD,  Nicolas M. Van Mieghem MD, PhD, 
  • Pages: 1270-1278
  • First Published: 21 December 2020

EDITORIAL COMMENT

Large-bore vascular closure: Evolution not revolution for now

Zoltan G. Turi MD, MSCAI FACC, 
  • Pages: 1279-1280
  • First Published: 11 May 2021
Key Points

  • Closure technology has expanded modestly since the dawn of transcatheter aortic valve replacement (TAVR)—most improvements in outcomes have come from evolving techniques, smaller TAVR devices, better operator skills, and lower risk patients.
  • The MANTA device adapts a well-established sandwiching of a resorbable anchor and collagen plug to large-bore closure.
  • The choice of large-bore closure devices will remain one of the operator's preference pending a sufficiently powered randomized trial.

ORIGINAL STUDIES

Open Access

12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation

Mitsunobu Kitamura MD,  Neil P. Fam MD,  Daniel Braun MD,  Tobias Ruf MD,  Atsushi Sugiura MD,  Akhil Narang MD,  Kim A. Connelly MD,  Edwin Ho MD,  Michael Nabauer MD,  Jörg Hausleiter MD,  Marcel Weber MD,  Georg Nickenig MD,  Charles J. Davidson MD,  Holger Thiele MD,  Ralph Stephan von Bardeleben MD,  Philipp Lurz MD, PhD, 
  • Pages: 1281-1289
  • First Published: 04 March 2021

Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users

Yasir N. Akhtar MBBS,  William A. Walker MD,  Umar Shakur DO,  Gary Smith RCDS,  Syed S. Husnain MD,  Shade F. Adigun PhD, FNP-BC, 
  • Pages: 1290-1295
  • First Published: 01 March 2021

CASE REPORT

Successful impella-assisted suction thrombectomy of right heart thrombus via the AngioVac device: Advantages, limitations, and alternatives

Shahrad Shadman MD, MS,  Stephen Heyliger BS,  Carolyn Watts MPH,  Nima Aghili MD, 
  • Pages: 1296-1300
  • First Published: 12 February 2021

HEMODYNAMIC ROUNDS

Disparate impact of severe aortic and mitral regurgitation on left ventricular dilation

Jason P. Schott DO,  Simon R. Dixon MBChB,  James A. Goldstein MD, 
  • Pages: 1301-1308
  • First Published: 20 January 2021

CORONARY ARTERY DISEASE

ORIGINAL STUDIES

Mid-term follow-up of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: An experience in Latin America

Pablo Sepúlveda MD,  René Hameau MD,  Christian Backhouse MD,  Gustavo Charme MD,  Francisco Pacheco MD,  Pablo A. Ramírez MD,  Alberto J. Fuensalida MD,  Jorge Quitral MD,  Gonzalo Martínez MD, MPhil,  José A. Martínez MD, 
  • Pages: E748-E757
  • First Published: 15 October 2020

Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk

Ko Yamamoto MD,  Hiroki Shiomi MD,  Takeshi Morimoto MD, MPH,  Yasuaki Takeji MD,  Yusuke Yoshikawa MD,  Masahiro Natsuaki MD,  Hirotoshi Watanabe MD,  Tomohisa Tada MD,  Junichi Tazaki MD,  Kyohei Yamaji MD,  Toshihiro Tamura MD,  Kenji Ando MD,  Kazushige Kadota MD,  Yutaka Furukawa MD,  Yoshihisa Nakagawa MD,  Takeshi Kimura MD, 
  • Pages: E758-E770
  • First Published: 16 October 2020

Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta-analysis of over 3,000 patients

Usaid K. Allahwala MBBS, FRACP,  Daniel Nour MBBS,  Kunwardeep Bhatia MBBS,  Michael R. Ward MBBS, PhD, FRACP,  Sidney Lo MBBS, FRACP,  James C. Weaver MBBS, PhD, FRACP,  Ravinay Bhindi MBBS, PhD, FRACP, 
  • Pages: E771-E777
  • First Published: 29 October 2020

A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention

Muhammad J. Ahsan MD,  Noman Lateef MD,  Azka Latif MD,  Saad U. Malik MD,  Syeda S. Batool MD,  Hafiz M. Fazeel MD,  Mohammad Z. Ahsan MBBS,  Zaheer Faizi MD,  Abhishek Thandra MD,  Mohsin Mirza MBBS,  Amjad Kabach MD, FACC,  Michael Del Core MD, FACC, 
  • Pages: E778-E788
  • First Published: 24 November 2020

Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel

Andrea Scotti MD,  Cosmo Godino MD,  Andrea Munafò MD,  Carlo A. Pivato MD,  Mauro Chiarito MD,  Giorgio Fiore MD,  Silvana Di Maio MD,  Pasquale Vergara MD,  Paolo Della Bella MD,  Mauro Carlino MD,  Alberto Margonato MD,  Antonio Colombo MD, 
  • Pages: E789-E800
  • First Published: 17 December 2020

Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention

Jason E Bloom BSc, MBBS,  Diem T Dinh BSc, PhD,  Samer Noaman MBChB,  Catherine Martin PhD,  Michael Lim MBBS,  Riley Batchelor MBBS,  Wayne Zheng,  Christopher Reid B.A, Dip Ed, MSc, PhD,  Angela Brennan RN,  Jeffrey Lefkovits MBBS,  Nicholas Cox MBBS,  Stephen J Duffy MBBS, PhD,  William Chan MBBS, PhD, 
  • Pages: E801-E809
  • First Published: 16 December 2020

BASIC SCIENCE

Association between distance from the radiation source and radiation exposure: A phantom-based study

Samir B. Pancholy MD, FAHA, FACC, FSCAI,  Michael Payne BS,  Pariseema S. Pancholy,  Gaurav A. Patel MD,  Saurabh Patel MD,  Sanjay C. Shah MD,  Prashant Kaul MD,  Shivam A. Pancholy,  Tejas M. Patel MD, 
  • Pages: E810-E816
  • First Published: 03 September 2020

INTERVENTIONAL ROUNDS

An algorithmic approach to balloon-uncrossable coronary lesions

Mahmoud M. Elrayes MD, PhD,  Iosif Xenogiannis MD,  Ilias Nikolakopoulos MD,  Evangelia Vemmou MD,  Jason Wollmuth MD,  Nidal Abi Rafeh MD,  Dimitri Karmpaliotis MD, PhD,  Gabriele L. Gasparini MD,  Martin Nicholas Burke MD,  Emmanouil S. Brilakis MD, PhD, 
  • Pages: E817-E825
  • First Published: 31 August 2020

PEDIATRIC AND CONGENITAL HEART DISEASE

CASE REPORTS

Ductal stent endocarditis resulting in a large aortic pseudoaneurysm

Matthew C. Schwartz MD,  Keerti Dantuluri MD, MPH,  Thomas Maxey MD,  Joseph Paolillo MD, 
  • Pages: E826-E829
  • First Published: 04 March 2021

Atrial flow regulator for drug-resistant pulmonary hypertension in a young child

Ellen Vanhie MD,  Kristof VandeKerckhove MD, PhD,  Nikolaus A. Haas MD, PhD,  Daniel De Wolf MD, PhD, 
  • Pages: E830-E834
  • First Published: 02 March 2021

PERIPHERAL VASCULAR DISEASE

CASE REPORTS

Morphological stabilization and regression of carotid plaque following therapy with evolocumab in a high-risk patient

Tiziana Claudia Aranzulla MD, MS,  Giuseppe Musumeci MD, 
  • Pages: E835-E841
  • First Published: 26 August 2020

Medial-to-lateral plantar loop technique for retrograde transcollateral recanalization of the lateral plantar artery in patients with type 3 plantar arch

Gabriele Testi MD, PhD,  Tanja Ceccacci MD, PhD,  Filippo Maioli MD,  Simone Grotti MD, 
  • Pages: E842-E846
  • First Published: 31 August 2020

Endovascular embolization of a lower limb arteriovenous fistula using a vascular plug deployed with a through-and-through arteriovenous access

Alessandro Grandi MD,  Andrea Melloni MD,  Roberto Chiesa MD,  Luca Bertoglio MD, 
  • Pages: E847-E851
  • First Published: 02 October 2020

Feasibility of the novel proximal superficial femoral artery puncture technique to recanalize chronic total occlusions

Tomoya Fukagawa MD,  Shinsuke Mori MD,  Keisuke Hirano MD, 
  • Pages: E852-E856
  • First Published: 05 October 2020

VALVULAR AND STRUCTURAL HEART DISEASES

ORIGINAL STUDIES

Association of baseline kidney disease with outcomes of transcatheter mitral valve repair by MitraClip

Hitesh Raheja MD,  Keerat Rai Ahuja MD,  Salik Nazir MD,  Anas M. Saad MD,  Mohamed M. Gad MD,  Saurav Chatterjee MD,  Omar M. Abdelfattah MD,  Mohamed Hassanein MD,  Serge Harb MD,  Samir R. Kapadia MD, 
  • Pages: E857-E867
  • First Published: 23 July 2020

Acute kidney injury after MitraClip implantation in patients with severe mitral regurgitation

Ivaylo Tonchev MD,  Dan Heberman MD,  Alona Peretz MD,  Anna Turyan Medvedovsky MD,  Israel Gotsman MD,  Yonatan Rashi MD,  Lion Poles MD,  Sorel Goland MD,  Gidon Y. Perlman MD,  Haim D. Danenberg MD,  Ronen Beeri MD,  Mony Shuvy MD, 
  • Pages: E868-E874
  • First Published: 31 August 2020

Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry

Hiromu Hase MD,  Nobuhiro Yoshijima MD,  Ryo Yanagisawa MD,  Makoto Tanaka MD,  Hikaru Tsuruta MD,  Hideyuki Shimizu MD,  Keiichi Fukuda MD,  Toru Naganuma MD,  Kazuki Mizutani MD,  Masahiro Yamawaki MD,  Norio Tada MD,  Futoshi Yamanaka MD,  Shinichi Shirai MD,  Minoru Tabata MD,  Hiroshi Ueno MD,  Kensuke Takagi MD,  Yusuke Watanabe MD,  Masanori Yamamoto MD,  Kentaro Hayashida MD, PhD, FESC, FACC, FJCS,  OCEAN-TAVI Investigators , 
  • Pages: E875-E886
  • First Published: 14 September 2020

CASE REPORTS

Transcatheter mitral valve thrombosis: A case report and literature review

Mohammad Alarfaj MBBS,  Tushina Jain MD,  Joseph Krepp MD, 
  • Pages: E887-E892
  • First Published: 11 November 2020

Computer-assisted valve in valve in a deteriorated Mosaic valve using a library of bioprostheses

Reda Belhaj Soulami MD,  Miguel Castro PhD,  Pascal Haigron PhD,  Jean-Philippe Verhoye MD, PhD, 
  • Pages: E893-E896
  • First Published: 19 November 2020

Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of “Eustachian ridge?”

Mohammed Qintar MD, MSc,  Dee Dee Wang MD,  William W O'Neill MD,  Brian O'Neill MD, 
  • Pages: E897-E899
  • First Published: 25 January 2021